MedTrace Logo

Identification of Tongue Involvement in Late-Onset Pompe Disease

NCT02765828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2021-07-06

No results posted yet for this study

Summary

This purpose of this study is to determine if tongue strength and tongue ultrasound measurements differentiates patients with untreated late-onset Pompe Disease (LOPD) from patients with acquires/hereditary myopathies or neuropathies. It is hypothesized that abnormalities in tongue function and structure in patients with LOPD may be useful in discriminating this condition from others that have similar presentations.

Conditions

  • Myopathy
  • Neuropathy
  • Glycogen Storage Disease Type II (Late-onset Pompe Disease)

Interventions

OTHER

Observational study

The following exams will be done in all cohorts: tongue manual muscle testing (MMT), tongue quantitative muscle testing, tongue ultrasound measurements

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    collaborator INDUSTRY

  • Duke University

    lead OTHER

Principal Investigators

  • Harrison Jones, PhD · Division of Head and Neck Surgery & Communication Sciences, Duke University Medical Center

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-25
Primary Completion
2019-07-15
Completion
2019-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765828 on ClinicalTrials.gov